Clinical trial
Treating Drug-Resistant Childhood Schizophrenia
NCT00048828 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00048828 |
|---|---|
| Title | Treating Drug-Resistant Childhood Schizophrenia |
| Official title | Treating Refractory Childhood Schizophrenia |
| Lead sponsor | Northwell Health, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Olanzapine, Clozapine |
| Enrollment | 41 |
| Start date | Oct 1, 2001 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Nov 13, 2002 |
| Last update posted | Jul 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: